High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia

NCT07559331 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Primary Immune Thrombocytopenia (ITP)

Interventions

DRUG: High-Dose Dexamethasone Combined with Orelabrutinib
DRUG: High-Dose Dexamethasone Combined with Placebo

Sponsor

Shandong University